Literature DB >> 21306292

Esophageal preservation in five male patients after endoscopic inner-layer circumferential resection in the setting of superficial cancer: a regenerative medicine approach with a biologic scaffold.

Stephen F Badylak1, Toshitaka Hoppo, Alejandro Nieponice, Thomas W Gilbert, Jon M Davison, Blair A Jobe.   

Abstract

As a result of injury caused by chronic gastroesophageal reflux, Barrett's esophagus with high-grade dysplasia and esophageal adenocarcinoma are rapidly increasing problems in the United States. The current standard of care involves esophagectomy, a procedure associated with a high morbidity, a negative impact on long term quality of life, and a mortality rate of 1-6 percent. An entirely endoscopic technique for circumferential, long segment en bloc removal of the mucosa and submucosa with subsequent placement of a biologic scaffold material that promotes a constructive remodeling response and minimizes stricture is described herein. The results of this approach are reported for five patients with 4-24-month follow-up. Restoration of normal mature, K4+/K14+, squamous epithelium, and return to a normal diet without significant dysphagia is reported for all patients. Two of five patients show a small focus of recurrent Barrett's esophagus at the gastroesophageal junction, but the entire length and circumference of the reconstituted esophageal mucosa remains free of disease. This experience provides evidence that a regenerative medicine approach may, for the first time, enable aggressive endoscopic resection of early stage neoplasia without the need for esophagectomy and its associated complications.

Entities:  

Mesh:

Year:  2011        PMID: 21306292      PMCID: PMC3098955          DOI: 10.1089/ten.TEA.2010.0739

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  48 in total

1.  Tissue-engineered rotator cuff tendon using porcine small intestine submucosa. Histologic and mechanical evaluation in dogs.

Authors:  L M Dejardin; S P Arnoczky; B J Ewers; R C Haut; R B Clarke
Journal:  Am J Sports Med       Date:  2001 Mar-Apr       Impact factor: 6.202

2.  Xenogeneic extracellular matrix grafts elicit a TH2-restricted immune response.

Authors:  A J Allman; T B McPherson; S F Badylak; L C Merrill; B Kallakury; C Sheehan; R H Raeder; D W Metzger
Journal:  Transplantation       Date:  2001-06-15       Impact factor: 4.939

3.  Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients.

Authors:  Roos E Pouw; Stefan Seewald; Joep J Gondrie; Pierre H Deprez; Hubert Piessevaux; Heiko Pohl; Thomas Rösch; Nib Soehendra; Jacques J Bergman
Journal:  Gut       Date:  2010-06-04       Impact factor: 23.059

Review 4.  Endoscopic mucosal resection in the management of esophageal neoplasia: current status and future directions.

Authors:  Vikneswaran Namasivayam; Kenneth K Wang; Ganapathy A Prasad
Journal:  Clin Gastroenterol Hepatol       Date:  2010-06-10       Impact factor: 11.382

5.  Resorbable bioscaffold for esophageal repair in a dog model.

Authors:  S Badylak; S Meurling; M Chen; A Spievack; A Simmons-Byrd
Journal:  J Pediatr Surg       Date:  2000-07       Impact factor: 2.545

6.  Clinical application of an acellular biologic scaffold for surgical repair of a large, traumatic quadriceps femoris muscle defect.

Authors:  Vincent J Mase; Joseph R Hsu; Steven E Wolf; Joseph C Wenke; David G Baer; Johnny Owens; Stephen F Badylak; Thomas J Walters
Journal:  Orthopedics       Date:  2010-07-13       Impact factor: 1.390

7.  Impact of anastomotic leak on outcomes after transhiatal esophagectomy.

Authors:  Matthew J Schuchert; Ghulam Abbas; Katie S Nason; Arjun Pennathur; Omar Awais; Marco Santana; Raphael Pereira; Alicia Oostdyk; James D Luketich; Rodney J Landreneau
Journal:  Surgery       Date:  2010-08-30       Impact factor: 3.982

8.  Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.

Authors:  Jennifer Chennat; Vani J A Konda; Andrew S Ross; Alberto Herreros de Tejada; Amy Noffsinger; John Hart; Shang Lin; Mark K Ferguson; Mitchell C Posner; Irving Waxman
Journal:  Am J Gastroenterol       Date:  2009-08-18       Impact factor: 10.864

9.  Transoral endoscopic inner layer esophagectomy: management of high-grade dysplasia and superficial cancer with organ preservation.

Authors:  Bart P L Witteman; Tyler J Foxwell; Sandy Monsheimer; Andres Gelrud; George M Eid; Alejandro Nieponice; Robert W O'Rourke; Toshitaka Hoppo; Nicole D Bouvy; Stephen F Badylak; Blair A Jobe
Journal:  J Gastrointest Surg       Date:  2009-10-14       Impact factor: 3.452

Review 10.  Macrophage and dendritic cell phenotypic diversity in the context of biomaterials.

Authors:  Peng Meng Kou; Julia E Babensee
Journal:  J Biomed Mater Res A       Date:  2010-11-10       Impact factor: 4.396

View more
  73 in total

1.  Electrodiagnostic Evaluation of Individuals Implanted With Extracellular Matrix for the Treatment of Volumetric Muscle Injury: Case Series.

Authors:  Nami Han; Mohammad A Yabroudi; Kristen Stearns-Reider; Wendy Helkowski; Brian M Sicari; J Peter Rubin; Stephen F Badylak; Michael L Boninger; Fabrisia Ambrosio
Journal:  Phys Ther       Date:  2015-11-12

2.  Transplantation of tissue-engineered cell sheets for stricture prevention after endoscopic submucosal dissection of the oesophagus.

Authors:  Eduard Jonas; Sebastian Sjöqvist; Peter Elbe; Nobuo Kanai; Jenny Enger; Stephan L Haas; Ammar Mohkles-Barakat; Teruo Okano; Ryo Takagi; Takeshi Ohki; Masakazu Yamamoto; Makoto Kondo; Katrin Markland; Mei Ling Lim; Masayuki Yamato; Magnus Nilsson; Johan Permert; Pontus Blomberg; J-Matthias Löhr
Journal:  United European Gastroenterol J       Date:  2016-02-19       Impact factor: 4.623

3.  Partial characterization of the Sox2+ cell population in an adult murine model of digit amputation.

Authors:  Vineet Agrawal; Bernard F Siu; Hsu Chao; Karen K Hirschi; Eric Raborn; Scott A Johnson; Stephen Tottey; Katherine B Hurley; Chris J Medberry; Stephen F Badylak
Journal:  Tissue Eng Part A       Date:  2012-06-05       Impact factor: 3.845

Review 4.  Extracellular matrix as an inductive scaffold for functional tissue reconstruction.

Authors:  Bryan N Brown; Stephen F Badylak
Journal:  Transl Res       Date:  2013-11-08       Impact factor: 7.012

Review 5.  Macrophage phenotype in response to ECM bioscaffolds.

Authors:  Luai Huleihel; Jenna L Dziki; Joseph G Bartolacci; Theresa Rausch; Michelle E Scarritt; Madeline C Cramer; Tatiana Vorobyov; Samuel T LoPresti; Ilea T Swineheart; Lisa J White; Bryan N Brown; Stephen F Badylak
Journal:  Semin Immunol       Date:  2017-07-21       Impact factor: 11.130

Review 6.  Regenerative Medicine Strategies for Esophageal Repair.

Authors:  Ricardo Londono; Stephen F Badylak
Journal:  Tissue Eng Part B Rev       Date:  2015-04-30       Impact factor: 6.389

Review 7.  Regenerative medicine for the esophagus.

Authors:  Kengo Kanetaka; Shinichiro Kobayashi; Susumu Eguchi
Journal:  Surg Today       Date:  2017-12-06       Impact factor: 2.549

8.  Esophagus and regenerative medicine.

Authors:  Ricardo Londono; Blair A Jobe; Toshitaka Hoppo; Stephen F Badylak
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

9.  A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy.

Authors:  Matthew T Wolf; Sudipto Ganguly; Tony L Wang; Christopher W Anderson; Kaitlyn Sadtler; Radhika Narain; Christopher Cherry; Alexis J Parrillo; Benjamin V Park; Guannan Wang; Fan Pan; Saraswati Sukumar; Drew M Pardoll; Jennifer H Elisseeff
Journal:  Sci Transl Med       Date:  2019-01-30       Impact factor: 17.956

10.  Non-viral gene-activated matrices: next generation constructs for bone repair.

Authors:  Erica G Tierney; Garry P Duffy; Sally-Ann Cryan; Caroline M Curtin; Fergal J O'Brien
Journal:  Organogenesis       Date:  2013-01-01       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.